WebFlowView Diagnostics develops an algorithm that analyses raw data from a cytometry machine to detect Minimal Residual Disease (MRD) in leukemia and inflammatory diseases. More cells are processed and MRD is detected more precisely compared to expert analysis. Because of this FlowView aims to improve diagnostics and patient care, at a lower cost ... WebThe combination of recently developed automated point-of-care flow cytometry devices and the ECLIPSE algorithm developed by Radboud University of Nijmegen make it possible to bring this point-of-care analysis to the clinic. FlowView Diagnostics BV has partnered with Radboud University Nijmegen and UMCU to convert the available technology into a ...
Slickline and Wireline Well Diagnostics SLB - Schlumberger
WebFlowView Diagnostics is expanding its team, please meet Mathijs Kuipers, our Clinical Application Specialist. With his master’s in Biomedical Science… Gemarkeerd als interessant door Jesse Siers. Neem nu deel om alle … WebFlowView Diagnostics Multi-parameter flow cytometry is a powerful analytical tool, enabling rapid measurement of multiple, physical and chemical characteristics of … cycloplegics and mydriatics
FlowView Diagnostics – NLC
WebFounded Date Apr 29, 2024. Operating Status Active. Last Funding Type Seed. Legal Name FlowView Diagnostics B.V. Company Type For Profit. Contact Email [email protected]. … WebIntelligent Decision Support is the future of patient care. Powered by AI, the Asudes platform is a Clinical Decision Support Platform for Flow cytometry that helps analyzing very … The fast growing advancements in MFC have led to the possibility of measuring … FLOWVIEW DIAGNOSTICS. Featured Publications. Flow cytometric evaluation … FlowView diagnostics was founded by NLC – the European Healthtech Venture … To learn more about FlowView for your organization / hospital or as investor and … FlowView Diagnostics raises €875,000 for further development. FlowView … WebFlowView Diagnostics has raised a total of €2.7M in funding over 2 rounds. Their latest funding was raised on Jun 24, 2024 from a Seed round. FlowView Diagnostics is funded by 2 investors. Amatis and NLC are the most recent investors. cyclopithecus